Polymorph control of sulfathiazole in supercritical CO2

Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide

Supercritical carbon dioxide (CO₂) has been used as a processing technique to control polymorphism of pharmaceuticals. However, there are fewer reports of novel polymorphs being discovered by supercritical CO₂ processing. As supercritical crystallization methods gain attention for potential in pharmaceutical processing, they may become a critical screening tool for discovery of new polymorphs. In this work, a case study is presented for a novel crystalline form of the anthelmintic drug, Praziquantel, found through supercritical CO₂ processing. The novel form of Praziquantel was characterized by chromatography, nuclear magnetic resonance and infrared spectroscopy, X-ray powder diffraction, thermal analysis, and scanning electron microscopy. Furthermore, the novel form exhibited 13-20% improved solubility compared to commercial Form A between pH 1.6 and 7.5 and was physically stable under stressed conditions (40 °C and 75% relative humidity) for 7.5 weeks. Overall, this work showed that supercritical CO₂ processing is a valuable tool to screen for novel, and possibly viable polymorphs of pharmaceutical compounds with improved properties.

Simultaneous control of polymorph and morphology via gelatin induction for concomitant system: case study of sulfathiazole

Controlling the solid-state properties is particularly important in the pharmaceutical field, where polymorph and morphology have a significant impact on drug properties. Sulfathiazole (ST) is a highly and concomitantly polymorphic...

A critical review on the particle generation and other applications of rapid expansion of supercritical solution

The novel particle generation processes of Active Pharmaceutical Ingredient (API)/drug have been extensively explored in recent decades due to their wide-range applications in the pharmaceutical industry. The Rapid Expansion of Supercritical Solutions (RESS) is one of the promising techniques to obtain the fine particles (micro to nano-size) of APIs with narrow particle size distribution (PSD). In RESS, supercritical carbon dioxide (SC CO₂) and API are used as solvent and solute respectively. In this literature survey, the application of RESS in the formation of fine particles is critically reviewed. Solubility of API in SC CO₂ and supersaturation are the key factors in tuning the particle size. The different approaches to model and predict the solubility of API in SC CO₂ are discussed. Then, the effect of process parameters on mean particle size and the particle size distribution are interpreted in the context of solubility and supersaturation. Furthermore, the less-explored applications of RESS in preparation of solid-lipid nanoparticles, liposome, polymorphic conversion, cocrystallization and inclusion complexation are compared with traditional processes. The solubility enhancement of API in SC CO₂ using co-solvent and its applications in particle generation are explored in published literature. The development and modifications in the conventional RESS process to overcome the limitations of RESS are presented. Finally, the perspective on RESS with special attention to its commercial operation is highlighted.

Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems

Micro- and nano-carrier formulations have been developed as drug delivery systems for active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, pharmacokinetic, and pharmacodynamic properties. Encapsulating the APIs in such systems can help improve their stability by protecting them from harsh conditions such as light, oxygen, temperature, pH, enzymes, and others. Consequently, the API's dissolution rate and bioavailability are tremendously improved. Conventional techniques used in the production of these drug carrier formulations have several drawbacks, including thermal and chemical stability of the APIs, excessive use of organic solvents, high residual solvent levels, difficult particle size control and distributions, drug loading-related challenges, and time and energy consumption. This review illustrates how supercritical fluid (SCF) technologies can be superior in controlling the morphology of API particles and in the production of drug carriers due to SCF's non-toxic, inert, economical, and environmentally friendly properties. The SCF's advantages, benefits, and various preparation methods are discussed. Drug carrier formulations discussed in this review include microparticles, nanoparticles, polymeric membranes, aerogels, microporous foams, solid lipid nanoparticles, and liposomes.

Co-crystallization and polymorphic behaviour of 5-fluorouracil

Hydrogen donors and acceptors in 5-fluorouracil allow the formation of co-crystalline compounds with nontoxic co-formers of the GRAS list and an alternative target-oriented synthon approach from methanol or ethanol to form II of 5-fluorouracil is presented.

Application of Chemometrics Approaches to Analysis of Mid-Infrared Spectra of Ibuprofen Diluted in Supercritical Carbon Dioxide

This work represents a comprehensive analysis of mid-infrared (mid-IR) spectra of ibuprofen diluted in supercritical CO₂ (in the temperature range of 40-90 ℃ and at the CO₂ density corresponding to 1.3 of its critical value). The study employed mathematical approaches based on data matrix analysis such as two-dimensional cross-correlation analysis (2D-COS) and principal component analysis (PCA). Two-dimensional cross-correlation analysis allowed us to reveal correlations between the spectral contributions constituting the analytical spectral band and assigned to certain ibuprofen conformers, as well as the significance of these correlations. It has been shown that the considerable increase in the total intensity of the analytical spectral band, proportional to the equilibrium ibuprofen concentration in the supercritical CO₂ phase, is accompanied by certain redistribution of intensities of the spectral components related to the corresponding conformers. The PCA allowed us to determine the changes of intensities of individual spectral contributions for each thermodynamic point in the considered temperature range. It has been shown that these two complementary methods provide more precise information that may be used as the initial data in the classical analysis of spectral data based on spectral curve deconvolution into individual spectral contributions.

Revealing the roles of solvation in D-mannitol's polymorphic nucleation

Using the different solvating powers of solvents, molecular distribution within solutions can be changed, leading to distinct solvation patterns that ultimately affect polymorphic outcomes.

Preparation of pharmaceutical co-crystals through sustainable processes using supercritical carbon dioxide: a review

The preparation of pharmaceutical co-crystals using supercritical CO₂ (scCO₂) is reviewed.

Influence of isomerism on recrystallization and cocrystallization induced by CO2 as an antisolvent

The position of the amine group in aminosalicylic acid has a significant impact not only on polymorph or cocrystal formation but also on the crystal shape during crystallization using CO₂ as an antisolvent.

Experimental Electron Density and Neutron Diffraction Studies on the Polymorphs of Sulfathiazole

High resolution X-ray diffraction data on forms I-IV of sulfathiazole and neutron diffraction data on forms II-IV have been collected at 100 K and analyzed using the Atoms in Molecules topological approach. The molecular thermal motion as judged by the anisotropic displacement parameters (adp's) is very similar in all four forms. The adp of the thiazole sulfur atom had the greatest amplitude perpendicular to the five-membered ring, and analysis of the temperature dependence of the adps indicates that this is due to genuine thermal motion rather than a concealed disorder. A minor disorder (∼1-2%) is evident for forms I and II, but a statistical analysis reveals no deleterious effect on the derived multipole populations. The topological analysis reveals an intramolecular S-O···S interaction, which is consistently present in all experimental topologies. Analysis of the gas-phase conformation of the molecule indicates two low-energy theoretical conformers, one of which possesses the same intramolecular S-O···S interaction observed in the experimental studies and the other an S-O···H-N intermolecular interaction. These two interactions appear responsible for "locking" the molecular conformation. The lattice energies of the various polymorphs computed from the experimental multipole populations are highly dependent on the exact refinement model. They are similar in magnitude to theoretically derived lattice energies, but the relatively high estimated errors mean that this method is insufficiently accurate to allow a definitive stability order for the sulfathiazole polymorphs at 0 K to be determined.

Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals

Solid-state, crystallographic purity and careful monitoring of the polymorphism of drugs and excipients are currently an integral part of the development of modern drug delivery systems. The reproducible preparation of organic crystals in a specific form and size is a major issue that must be addressed. A recent approach for obtaining pharmaceutical materials in pure physical form is represented by the technologies based on supercritical fluids. The present work aims to provide a critical review of the recent advances in the use of supercritical fluids for the preparation and control of the specific physical form of pharmaceutical substances with particular attention to those fluids used for drug delivery systems. These innovative technologies are highly promising for future application in particle design and engineering.

Separation processes for organic molecules using SCF Technologies

Supercritical fluids have been applied for many years for the separation of solutes from solids or solute mixtures in both exploratory and industrial applications. In the pharmaceutical industry the generation of pure solid states without impurities is important as the presence of impurities can result in a change in chemical properties or lead to physical instability. The literature on the separation and purification of solutes from solid matrices and solute mixtures using supercritical fluids, with the main emphasis on pharmaceutically important molecules, is reviewed in this article. Also discussed is the application of supercritical fluids in the control of process impurities such as chemical intermediates and residual solvent and in polymorphic control and chiral resolution. As the generation of organic molecules of pharmaceutical interest with high purity is important in pharmaceuticals this review additionally provides a brief overview of highly selective chemical reactions in supercritical fluids.

Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation

Supercritical fluid technique have been exploited in extraction, separation and crystallization processes. In the field of pharmaceutics, supercritical carbon dioxide (scCO(2)) has been used for the purpose of micronization, polymorphic control, and preparation of solid dispersion and complexes. Particle design of active pharmaceutical ingredients is important to make the solid dosage forms with suitable physicochemical properties. Control of the characteristic properties of particles, such as size, shape, crystal structure and morphology is required to optimize the formulation. For solubility enhancement of poorly water-soluble drugs, preparation of the solid dispersion or the complexation with proper drugs or excipients should be a promising approach. This review focuses on aspects of polymorphic control and complexation behavior of active pharmaceutical ingredients by scCO(2) processing.

Polymorph Farming of Acetaminophen and Sulfathiazole on a Chip

PURPOSE

The aim of this paper is to understand at a given temperature (1) the role of template films, the droplet volume of a saturated sulfathiazole aqueous solution and the solvent on polymorph screening of sulfathiazole on a silicon wafer, and (2) the effect of template films on the acetaminophen crystal face at the template-crystal interface.

MATERIALS AND METHODS

Template Effect: Spun cast template films of non-annealed chitosan and annealed chitosan at 140 degrees C on silicon wafers were prepared. A 0.01-cm(3) saturated sulfathiazole aqueous solution droplets were deposited on both kinds of chitosan film. Sulfathiazole crystals were produced on those films by evaporation at 25 degrees C. Volume Effect: Different droplet volumes of a saturated sulfathiazole aqueous solution ranging from 0.01 to 0.14 to 2.7 cm(3) were deposited on non-annealed chitosan films. Sulfathiazole crystals were generated on those films by evaporation at 25 degrees C. Solvent Effect: 0.01 cm(3) saturated sulfathiazole methanol solution droplets were deposited on non-annealed chitosan films and sulfathiazole crystals were formed on those films by evaporation at 25 degrees C. The formation pathways of different sulfathiazole crystal polymorphs of the above mentioned effects were analyzed and verified by systematic studies. Template-crystal Interfacial Study: Millimeter-sized acetaminophen crystals were successfully grown on non-annealed chlorosulfonated poly(ethylene) (PE-Chl) and chitosan template films by cooling the saturated acetaminophen aqueous solution from 50 to 25 degrees C in which those template films were immersed. The bonding energies for specific carbons collected by electron spectroscopy for chemical analysis (ESCA) at the acetaminophen crystal surface, together with the molecular interactions between acetaminophen and PE-Chl and between acetaminophen and chitosan in separately prepared solid dispersion film samples detected by Fourier transformed infrared (FTIR) spectroscopy, proved to be useful for identifying the crystal face of acetaminophen essential for its specific intermolecular interactions at the template-crystal interface.

RESULTS

Thermodynamically metastable sulfathiazole Form I crystals were reproducibly obtained on the non-annealed chitosan films whereas the stable sulfathiazole Form III crystals were repeatedly formed on the annealed chitosan films. Droplet volumes and solvents were also found responsible for the polymorphic outcome of sulfathiazole in the kinetically driven area of two overlapping metastable zones from two competing polymorphs of Form I and Form III. Thermodynamically stable sulfathiazole Form III crystals were formed on the non-annealed chitosan films instead when the droplet volumes of a saturated sulfathiazole aqueous solution were increased from 0.01 to 0.14 cm(3) and 2.7 cm(3). When the solvent was changed from water to methanol, the thermodynamically stable sulfathiazole Form III crystals were again observed on the non-annealed chitosan films even from the 0.01 cm(3) saturated sulfathiazole methanol solution droplets.

CONCLUSIONS

Template surfaces were thought to provide specific functional groups to either change the energy barrier for the nuclei formation of the thermodynamically metastable Form I or alter the droplet contact angle and the droplet surface area which was related to the droplet evaporation time. The evaporation time determines the amount of time available for the polymorphic transformation from Form I to Form III. Apparently, droplet volumes could also determine the amount of time needed to reach supersaturation and the amount of time available for a polymorphic transformation from Form I to Form III. In addition, the molecular conformation and viscosity of solvents such as methanol might alter the original nucleation kinetics in water and lead to a more rapid polymorphic transformation from Form I to Form III. Template films of PE-Chl and chitosan were found to be critical for determining the face of a millimeter-sized acetaminophen crystal at the template-crystal interface. The idea of performing polymorph screening on the template film deposited on a chip has opened up a new doorway to examine the roles of: (1) various kinds of drug carrier in the form of a template film, (2) the droplet volume of a saturated solution, and (3) the type of solvent used, in polymorphic control. Growing millimeter-sized crystals directly on the chip of template has also provided a convenient technology enabling platform for examining the crystal-template interface by solid-state characterization techniques such as ESCA.

Recrystallization of fluconazole using the supercritical antisolvent (SAS) process

The supercritical antisolvent (SAS) process was used to modify solid state characteristics of fluconazole. Fluconazole was recrystallized at various temperatures (60-80 degrees C) and pressures (8-16MPa) using dichloromethane (DCM) as a solvent. Acetone and ethanol were also employed as solvents. The fluconazole polymorphs prepared by the SAS process were characterized by differential scanning calorimetry (DSC), thermogravimetry analysis (TGA), powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FT-IR) and scanning electron microscopy (SEM). Furthermore, the equilibrium solubility of the samples in aqueous solution was determined. Fluconazole anhydrate form I was obtained at low temperature (40 degrees C) and anhydrate form II was obtained at high temperature (80 degrees C). The variation of pressure during the SAS process may influence the preferred orientation. Anhydrate forms I and II were also obtained using various solvents. Therefore, it was shown that solid state characteristics of fluconazole, including the polymorphic form and preferred orientation, can be controlled by changing operating conditions of the SAS process such as temperature, pressure, and solvent.

A comparison of morphology and surface energy characteristics of sulfathiazole polymorphs based upon single particle studies

The morphological, adhesion and surface energetic properties of three sulfathiazole polymorphs (III, IV and polymorph I prepared from both acetone and methanol, designated I-ace and I-met, respectively) produced using Nektar supercritical fluid (SCF) technology have been characterized using scanning electron microscopy (SEM) and atomic force microscopy (AFM). Surface roughness values for each polymorph were determined at different length scales. At sample sizes less than 1micromx1microm the polymorphs rank in terms of roughness as follows: I-met>I-ace approximately equal to IV>III. At the larger scales the polymorphs rank in terms of roughness as follows: I-met>III>I-ace approximately equal to IV. The surface energies for polymorphs determined against graphite (HOPG) and particles of the same polymorph were, respectively, I-met: 0.99mJm(-2) (S.D. 1.25mJm(-2)), 3.09mJm(-2) (S.D. 2.67mJm(-2)); I-ace: 309mJm(-2) (S.D. 329mJm(-2)), 16mJm(-2) (S.D. 11mJm(-2)); III: 1.17mJm(-2) (S.D. 1.5mJm(-2)), 5.4mJm(-2) (S.D. 3.6mJm(-2)); IV: 20.35mJm(-2) (S.D. 28.5mJm(-2)), 16.8mJm(-2) (S.D. 9.6mJm(-2)). In terms of surface energies the polymorphs hence rank I-ace>IV>III approximately equal to I-met (HOPG adhesion measurements) and IV approximately equal to I-ace>III>I-met (particle cohesion measurements). Consideration of contacting asperities and surface roughness was shown to have limited effect on the surface energies, and instead the differences were ascribed to variations in the surface chemistry as a result of changes in crystallization mechanisms.